Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
16 February 2021 |
Main ID: |
NCT03343158 |
Date of registration:
|
10/11/2017 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Orphans and Vulnerable Children Risk Screening Tool Research Study (Zimbabwe)
|
Scientific title:
|
Orphans and Vulnerable Children Risk Screening Tool Research Study (Zimbabwe) |
Date of first enrolment:
|
October 17, 2017 |
Target sample size:
|
2260 |
Recruitment status: |
Terminated |
URL:
|
https://clinicaltrials.gov/show/NCT03343158 |
Study type:
|
Observational |
Study design:
|
|
Phase:
|
|
|
Countries of recruitment
|
Zimbabwe
| | | | | | | |
Contacts
|
Name:
|
Godfrey Woelk, PhD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Elizabeth Glaser Pediatric AIDS Foundation |
|
Name:
|
Agnes Mahomva, MD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Elizabeth Glaser Pediatric AIDS Foundation |
| |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Children/adolescents ages 2 up to 18 years living in a household and enrolled in
WEI/Zimbabwe and/or partners program;
- Children/adolescents ages 2 up to 18 years with HIV status unknown, or who tested
negative three or more months ago;
- Children/adolescents ages 2 up to 18 years who are healthy or ill (unless they are ill
enough to require immediate hospitalization).
Exclusion Criteria:
- Children/adolescents aged 2 up to 18 years tested HIV positive
- Children/adolescents ages 2 up to 18 years who require immediate hospitalization;
- Children/adolescents ages 2 up to 18 years who refuse/are refused participation.
Age minimum:
2 Years
Age maximum:
18 Years
Gender:
All
|
Health Condition(s) or Problem(s) studied
|
Community-based
|
Vulnerable Children, Adolescents
|
Orphans, Children, Adolescents
|
Primary Outcome(s)
|
Phase 1: Validity of various questions in predicting the probability of HIV among OVC (Screening tool)
[Time Frame: Four weeks]
|
Phase 2: Validation of combined questions in predicting HIV among OVC (Validating Screen tool)
[Time Frame: Six weeks]
|
Secondary Outcome(s)
|
Usability of screening tool
[Time Frame: Two weeks]
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|